Gross Profit Trends Compared: Pfizer Inc. vs Bausch Health Companies Inc.

Pfizer vs Bausch: A Decade of Gross Profit Trends

__timestampBausch Health Companies Inc.Pfizer Inc.
Wednesday, January 1, 2014600890000040028000000
Thursday, January 1, 2015785380000039203000000
Friday, January 1, 2016706300000040495000000
Sunday, January 1, 2017617600000041306000000
Monday, January 1, 2018602900000042399000000
Tuesday, January 1, 2019625100000041531000000
Wednesday, January 1, 2020577800000033216000000
Friday, January 1, 2021604000000050467000000
Saturday, January 1, 2022576000000065986000000
Sunday, January 1, 2023619800000028809000000
Monday, January 1, 202445776000000
Loading chart...

Infusing magic into the data realm

Gross Profit Trends: Pfizer Inc. vs Bausch Health Companies Inc.

In the ever-evolving pharmaceutical industry, understanding financial trends is crucial. From 2014 to 2023, Pfizer Inc. and Bausch Health Companies Inc. have shown distinct trajectories in their gross profits. Pfizer, a global leader, experienced a notable fluctuation, peaking in 2022 with a 56% increase from 2014, before dropping by 56% in 2023. In contrast, Bausch Health's gross profit remained relatively stable, with a modest 3% increase over the same period. This stability highlights Bausch's consistent market strategy, while Pfizer's volatility reflects its dynamic approach to innovation and market expansion. These trends offer valuable insights into the strategic decisions and market conditions influencing these pharmaceutical giants. As the industry continues to adapt to global challenges, monitoring such financial indicators will be key to understanding future market dynamics.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025